The application of statistical parametric mapping to 123I-FP-CIT SPECT in dementia with Lewy bodies, Alzheimer's disease and Parkinson's disease

NeuroImage

Volumn 23, Issue 3, 2004, Pages 956-966

  Colloby, Sean J ^a   O'Brien, John T ^a   Fenwick, John D ^b   Firbank, Michael J ^a   Burn, David J ^b   McKeith, Ian G ^a   Williams, E David ^c  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^c SUNDERLAND ROYAL HOSPITAL   (United Kingdom)

Author keywords

Dementia with lewy bodies; FPCIT; SPECT; Statistical parametric mapping

Indexed keywords

2BETA CARBOMETHOXY 3BETA (4 IODOPHENYL) N (3 FLUOROPROPYL) N NORTROPANE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; ARTICLE; AUTOMATION; CAUDATE NUCLEUS; CONTROLLED STUDY; CORPUS STRIATUM; DRUG BINDING; DRUG UPTAKE; FEMALE; HUMAN; LEWY BODY; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; PUTAMEN; RECEIVER OPERATING CHARACTERISTIC; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL PARAMETERS;

AGED; AGING; ALZHEIMER DISEASE; BRAIN; BRAIN MAPPING; COCAINE; DIAGNOSIS, DIFFERENTIAL; DOPAMINE; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LEWY BODY DISEASE; MALE; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; RADIOPHARMACEUTICALS; ROC CURVE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 7444224676     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2004.06.045     Document Type: Article

References (42)

1. Y.G. Abdullaev, and K.V. Melnichuk Cognitive operations in the human caudate nucleus Neurosci. Lett. 234 1997 151 155
2. Y.G. Abdullaev, N.P. Bechtereva, and K.V. Melnichuk Neuronal activity of human caudate nucleus and prefrontal cortex in cognitive tasks Behav. Brain Res. 97 1998 159 177
3. R. Barber, I. McKeith, C. Ballard, and J. O'Brien Volumetric MRI study of the caudate nucleus in patients with dementia with Lewy bodies, Alzheimer's disease, and vascular dementia J. Neurol., Neurosurg. Psychiatry 72 2002 406 407
4. H.T.S. Benamer, J. Patterson, D.J. Wyper, D.M. Hadley, G.J.A. Macphee, and D.G. Grosset Correlation of Parkinson's disease severity and duration with I-123-FP-CIT SPECT striatal uptake Mov. Disord. 15 2000 692 698
5. 123I]-FP-CIT study group Mov. Disord. 15 2000 503 510
6. 123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease J. Neurol., Neurosurg. Psychiatry 62 1997 133 140
7. 123I]FPCIT SPECT J. Nucl. Med. 40 1999 753 761
8. M. Brett The MNI Brain and The Talairach Atlas 1999
9. C. Chatfield, and A.J. Collins Introduction to Multivariate Analysis 1980 Chapman & Hall London
10. D.L. Collins, P. Neelin, T.M. Peters, and A.C. Evans Automatic 3d intersubject registration of Mr volumetric data in standardized talairach space J. Comput. Assist. Tomogr. 18 1994 192 205
11. J.L. Cummings, M. Mega, K. Gray, S. Rosenberg-Thompson, D.A. Carusi, and J. Gornbein The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia Neurology 44 1994 2308 2314
12. 123I-beta-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease Eur. J. Nucl. Med. 24 1997 320 325
13. S. Fahn, R.L. Elton, C.D. Marsden, and M. Goldstein Unified Parkinson's disease rating scale Recent developments in Parkinson's disease 1987 Macmillan
14. M.F. Folstein, S.E. Folstein, and P.R. McHugh "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician J. Psychiatr. Res. 12 1975 189 198
15. R.S. Frackowiak, K.J. Friston, C.D. Frith, R.J. Dolan, and J.C. Mazziotta Human Brain Function 1997 Academic Press
16. K.J. Friston, K.J. Worsley, R.S.J. Frackowiak, J.C. Mazziotta, and A.C. Evans Assessing the significance of focal activations using their spatial extent Hum. Brain Mapp. 1 1994 214 220
17. K.J. Friston, A.P. Holmes, K.J. Worsley, J.-P. Poline, C.D. Frith, and R.S.J. Frackowiak Statistical parametric maps in functional imaging: a general linear approach Hum. Brain Mapp. 2 1995 189 210
18. W.R.G. Gibb, and A.J. Lees The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease J. Neurol., Neurosurg. Psychiatry 51 1988 745 752
19. J.B. Habraken, J. Booij, P. Slomka, E.B. Sokole, and E.A. van Royen Quantification and visualization of defects of the functional dopaminergic system using an automatic algorithm J. Nucl. Med. 40 1999 1091 1097
20. K. Ito, P.K. Morrish, J.S. Rakshi, T. Uema, J. Ashburner, D.L. Bailey, K.J. Friston, and D.J. Brooks Statistical parametric mapping with F-18-dopa PET shows bilaterally reduced striatal and nigral dopaminergic function in early Parkinson's disease J. Neurol., Neurosurg. Psychiatry 66 1999 754 758
21. G.B. Karas, E.J. Burton, S. Rombouts, R.A. van Schijndel, J.T. O'Brien, P. Scheltens, I.G. McKeith, D. Williams, C. Ballard, and F. Barkhof A comprehensive study of gray matter loss in patients with Alzheimer's disease using optimized voxel-based morphometry NeuroImage 18 2003 895 907
22. N. Kemppainen, P. Marjamaki, M. Roytta, and J.O. Rinne Different pattern of reduction of striatal dopamine reuptake sites in Alzheimer's disease and ageing J. Neural Transm. 108 2001 827 836
23. J.L. Lancaster, M.G. Wordorff, L.M. Parsons, M. Liotti, C.S. Freitas, L. Rainey, P.V. Kochunov, D. Nickerson, S.A. Mikiten, and P.T. Fox Automated Talairach atlas labels for functional brain mapping Hum. Brain Mapp. 10 2000 120 131
24. G. Lucignani, C. Gobbo, R.M. Moresco, A. Antonini, A. Panzacchi, L. Bonaldi, A. Carpinelli, T. Caraceni, and F. Fazio The feasibility of statistical parametric mapping for the analysis of positron emission tomography studies using C-11-2-beta-carbomethoxy-3-beta-(4-fluorophenyl)-tropane in patients with movement disorders Nucl. Med. Commun. 23 2002 1047 1055
25. Y. Ma, V. Dhawan, M. Mentis, T. Chaly, P.G. Spetsieris, and D. Eidelberg Parametric mapping of F-18 FPCIT binding in early stage Parkinson's disease: a PET study Synapse 45 2002 125 133
26. F. Maes, A. Collignon, D. Vandermeulen, G. Marchal, and P. Suetens Multimodality image registration by maximization of mutual information IEEE Trans. Med. Imag. 16 1997 187 198
27. I.G. McKeith, D. Galasko, K. Kosaka, E.K. Perry, D.W. Dickson, L.A. Hansen, D.P. Salmon, J. Lowe, S.S. Mirra, E.J. Byrne, G. Lennox, N.P. Quinn, J.A. Edwardson, P.G. Ince, C. Bergeron, A. Burns, B.L. Miller, S. Lovestone, D. Collerton, E.N. Jansen, C. Ballard, R.A. de Vos, G.K. Wilcock, K.A. Jellinger, and R.H. Perry Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop Neurology 47 1996 1113 1124
28. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, and E.M. Stadlan Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 34 1984 939 944
29. C.E. Metz Basic principles of ROC analysis Semin. Nucl. Med. 8 1978 283 298
30. J.T. O'Brien, S. Colloby, J. Fenwick, E.D. Williams, M. Firbank, D. Burn, D. Aarsland, and I.G. McKeith Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies Arch. Neurol. 61 2004 919 925
31. G. Pizzolato, F. Chierichetti, M. Fabbri, A. Cagnin, M. Dam, G. Ferlin, and L. Battistin Reduced striatal dopamine receptors in Alzheimer's disease: single photon emission tomography study with the D-2 tracer I-123-IBZM Neurology 47 1996 1065 1068
32. J.O. Rinne, N. Sahlberg, H. Ruottinen, K. Nagren, and P. Lehikoinen Striatal uptake of the dopamine reuptake ligand C-11 beta-CFT is reduced in Alzheimer's disease assessed by positron emission tomography Neurology 50 1998 152 156
33. J.O. Rinne, H. Ruottinen, J. Bergman, M. Haaparanta, P. Sonninen, and O. Solin Usefulness of a dopamine transporter PET ligand F-18 beta-CFT in assessing disability in Parkinson's disease J. Neurol., Neurosurg. Psychiatry 67 1999 737 741
34. S.A. Rombouts, F. Barkhof, M.P. Witter, and P. Scheltens Unbiased whole-brain analysis of gray matter loss in Alzheimer's disease Neurosci. Lett. 285 2000 231 233
35. M. Roth, E. Tym, C.Q. Mountjoy, F.A. Huppert, H. Hendrie, S. Verma, and R. Goddard CAMDEX A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia Br. J. Psychiatry 149 1986 698 709
36. J.P. Seibyl, K. Marek, K. Sheff, S. Zoghbi, R.M. Baldwin, D.S. Charney, C.H. van Dyck, and R.B. Innis Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients J. Nucl. Med. 39 1998 1500 1508
37. H. Sjoholm, J. Sundsfjord, and S.I. Mellgren Beta-CIT-SPECT combined with UPDRS appears to distinguish different parkinsonian conditions Acta Neurol. Scand. 105 2002 5 7
38. J. Talairach, and P. Tournoux Co-planar Stereotactic Atlas of the Human Brain 1988 Thieme Stuttgart, NY
39. A. Varrone, K.L. Marek, D. Jennings, R.B. Innis, and J.P. Seibyl I-123 beta-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophy Mov. Disord. 16 2001 1023 1032
40. Z. Walker, D.C. Costa, R.W. Walker, K. Shaw, S. Gacinovic, T. Stevens, G. Livingston, P. Ince, I.G. McKeith, and C.L. Katona Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand J. Neurol., Neurosurg. Psychiatry 73 2002 134 140
41. Z. Walker, D.C. Costa, R.W.H. Walker, K. Shaw, S. Gacinovic, T. Stevens, G. Livingston, P. Ince, I.G. McKeith, and C.L.E. Katona Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand J. Neurol., Neurosurg. Psychiatry 73 2002 134 140
42. M.H. Zweig, and G. Campbell Receiver operating characteristic (Roc) plots-A fundamental evaluation tool in Clinical Medicine (Vol. 39, Pg. 561, 1993) Clin. Chem. 39 1993 1589